Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Intranasal Nerve Growth Factor for Traumatic Brain Injury
NCT01212679Phase 2Completed
- Sponsor
- Jinling Hospital
- Start
- Dec 2010
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Nerve growth factor in traumatic brain injury (TBI), sponsored by Jinling Hospital. Started Dec 2010; status: completed.
02
Drugs
Nerve growth factor
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01212679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212679.